Participant consumed grapefruit or grapefruit products and solutions within 3 times prior to the 1st dose of study drug. - "Our study disclosed the critical position from the KLF16/MYC regulatory axis in modulating tumor expansion and chemotherapy sensitivity in BLCA, suggesting that combining bromodomain inhibitors, including OTX015 or ABBV-744, with https://clinicaltrialrecruitmentf57912.webdesign96.com/32471662/what-does-new-advancements-in-brd4-inhibition-therapy-abbv-744-mean